An observational study in Gastritis H Pylori, Gastritis and Obesity Associated Disorder, sponsored by University of Jordan. Completed at 1 site in Jordan. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2021-11-08.
Sponsored by University of Jordan · Observational
This is a cross-sectional study looking for prevalence of H.Pylori related gastritis among patients underwent sleeve gastrectomy over five year study period. The study also looks for possible association with patients's characteristics. Also, compares its findings with similar regional and international studies.
196 studies on the registry are indexed under Gastritis; 42 are open to participants now.
This study's enrollment of 810 is above the median of 400 across 79 observational studies indexed under Gastritis.
Browse Gastritis studies →University of Jordan is the lead sponsor of 126 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Obese patients who undergo sleeve gastrectomy for bariatric reasons
Exclusion Criteria:
Patients who underwent sleeve gastrectomy and the histopathology result of resected gastric specimen showed the presence of gastritis in it.
Other: Giemsa stain
Giemsa special stain was employed for detection of H. Pylori microorganisms.
Prevalence of gastritis
proportion of patients who underwent sleeve gastrectomy who have gastritis in their resected gastric specimen at or during study period. calculated as (number of pt with gastritis / number of examined resected gastric specimens)
Time frame: start to end of the study, 5 years
Prevalence of H.pylori gastritis
proportion of patients who underwent sleeve gastrectomy who have H.pylori related gastritis in their resected gastric specimen at or during study period. calculated as (number of pt with H.pylori gastritis / number of examined resected gastric specimens)
Time frame: start to end of the study, 5 years
Prevalence of other histopathological findings
proportion of patients who underwent sleeve gastrectomy who have histopathological findings not including gastritis or H.pylori related gastritis in their resected gastric specimen at or during study period. calculated as (number of pt with the histopathological finding / number of examined resected gastric specimens)
Time frame: start to end of the study, 5 years
likelihood ratio between H.pylori gastritis and advancing age
The relationship between H.pylori gastritis and advancing age. likelihood ratio will be calculated by cross table analysis using Statistical Analysis Software SPSS program version 26.
Time frame: start to end of the study, 5 years
likelihood ratio between H.pylori gastritis and female gender
The relationship between H.pylori gastritis and female gender. likelihood ratio will be calculated by cross table analysis using Statistical Analysis Software SPSS program version 26.
Time frame: start to end of the study, 5 years
likelihood ratio between H.pylori gastritis and BMI
The relationship between H.pylori gastritis and body mass index (BMI). weight and height will be combined to report BMI in kg/m\^2 likelihood ratio will be calculated by cross table analysis looking for using Statistical Analysis Software SPSS program version 26.
Time frame: start to end of the study, 5 years
Plan to share: Undecided — We are not willing to share study data due to hospital policies, but data is available for interested researchers upon request after verification and masking through corresponding author.
This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Jordan